Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Everolimus and/or Nivolumab-As...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Everolimus and/or Nivolumab-Associated Cytomegalovirus Colitis in a Patient with Metastatic Renal Cell Carcinoma

Everolimus and/or Nivolumab-Associated Cytomegalovirus Colitis in a Patient with Metastatic Renal Cell Carcinoma

Bibliographic Details
Main Authors: Rashad Ismayilov, Oktay Halit Aktepe, Konul Sardarova, Can Berk Leblebici, Mustafa Erman
Format: Article
Language:English
Published: Atatürk University 2022-02-01
Series:Eurasian Journal of Medicine
Online Access:https://www.eajm.org/en/everolimus-and-or-nivolumab-associated-cytomegalovirus-colitis-in-a-patient-with-metastatic-renal-cell-carcinoma-133369
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.eajm.org/en/everolimus-and-or-nivolumab-associated-cytomegalovirus-colitis-in-a-patient-with-metastatic-renal-cell-carcinoma-133369

Similar Items

  • Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma
    by: Sabrina Rossetti, et al.
    Published: (2017-07-01)
  • Everolimus in the management of metastatic neuroendocrine tumours
    by: David L. Chan, et al.
    Published: (2017-01-01)
  • Everolimus in the Treatment of Metastatic Breast Cancer
    by: Melanie E. Royce, et al.
    Published: (2015-01-01)
  • Everolimus in the Treatment of Metastatic Breast Cancer
    by: Melanie E. Royce, et al.
    Published: (2015-09-01)
  • Cost-effectiveness comparison of cabozantinib with everolimus, axitinib, and nivolumab in the treatment of advanced renal cell carcinoma following the failure of prior therapy in England
    by: Meng J, et al.
    Published: (2018-04-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs